EMA
approval
· 2026-07-10
EMA Authorised: Vaxchora (vibrio cholerae, strain cvd 103-hgr, live) — Bavarian Nordic A/S
Summary
Vaxchora (live Vibrio cholerae, strain CVD 103-HgR) has been authorised by the EMA for use in cholera.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Status: Authorised. Therapeutic area: Cholera. MAH: Bavarian Nordic A/S. Decision date: 09/07/2026